Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Xiaoming Hu
Bilobalide (BB), a sesquiterpene isolated from Ginkgo biloba extract, has attracted great interest as a potential therapeutic agent for several neurological diseases. Multiple Sclerosis (MS) is a chronic immune-mediated inflammatory and neurodegenerative disease of the Central Nervous System (CNS), which results in demyelination and axonal degeneration. Experimental Autoimmune Encephalomyelitis (EAE), characterized by infiltration of T cells and macrophages, neuroinflammation and severe demyelination, is the best imitation and extensively used to study MS. The recent paper, “The therapeutic potential of bilobalide on Experimental Autoimmune Encephalomyelitis (EAE) mice”, provides evidence that BB protected myelin sheath by immunomodulatory, anti-inflammation and antiapoptosis. In this review, we discussed the findings of BB treatment on EAE.